Allegion PLC (NYSE:ALLE – Get Free Report) SVP Timothy Eckersley sold 6,417 shares of the business’s stock in a transaction on Monday, July 27th. The shares were sold at an average price of $157.26, for a total transaction of $1,009,137.42. Following the completion of the transaction, the senior vice president directly owned 29,919 shares in the company, valued at $4,705,061.94. This represents a 17.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Allegion Stock Down 1.7%
ALLE stock opened at $158.43 on Thursday. Allegion PLC has a one year low of $125.00 and a one year high of $183.11. The stock has a market capitalization of $13.47 billion, a PE ratio of 20.79, a price-to-earnings-growth ratio of 3.28 and a beta of 0.85. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.23 and a current ratio of 1.93. The company has a fifty day moving average of $136.68 and a 200-day moving average of $146.66.
Allegion (NYSE:ALLE – Get Free Report) last issued its earnings results on Thursday, July 23rd. The scientific and technical instruments company reported $2.40 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.18. The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.12 billion. Allegion had a net margin of 15.36% and a return on equity of 35.41%. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.04 earnings per share. Allegion has set its FY 2026 guidance at 8.850-9.000 EPS. As a group, analysts expect that Allegion PLC will post 8.92 EPS for the current year.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on ALLE. Robert W. Baird set a $170.00 target price on Allegion in a research note on Friday, July 24th. Barclays dropped their price objective on Allegion from $165.00 to $161.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 29th. Bank of America cut their price objective on Allegion from $185.00 to $157.00 and set a “neutral” rating for the company in a research report on Monday, April 20th. Wells Fargo & Company reduced their target price on Allegion from $175.00 to $155.00 and set an “equal weight” rating for the company in a report on Wednesday, April 1st. Finally, Morgan Stanley decreased their target price on shares of Allegion from $165.00 to $142.00 and set an “equal weight” rating on the stock in a research report on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $164.75.
View Our Latest Research Report on ALLE
Allegion News Summary
Here are the key news stories impacting Allegion this week:
- Positive Sentiment: Allegion’s recent quarterly performance remains a key support for the stock. The company reported adjusted EPS of $2.40, exceeding estimates of $2.22, while revenue rose 12.7% year over year to $1.15 billion, above the $1.12 billion consensus. Management reaffirmed fiscal 2026 EPS guidance of $8.85–$9.00. Allegion earnings and stock information
- Positive Sentiment: The company’s $500 million share-repurchase authorization, potentially covering about 3.9% of outstanding shares, may provide ongoing support by signaling management’s confidence in the valuation. Institutional investors also hold approximately 92.2% of the stock, with several funds recently increasing their positions. Allegion insider and institutional ownership information
- Positive Sentiment: Momentum-focused coverage continues to highlight Allegion as a potentially attractive long-term stock, supported by its earnings growth, solid profitability and performance above its longer-term moving averages. Zacks Allegion momentum article
- Neutral Sentiment: Allegion gained during Tuesday’s session but lagged several industry peers, suggesting the stock lacked a company-specific catalyst strong enough to outperform the broader group. MarketWatch Allegion performance article
- Negative Sentiment: Several executives disclosed stock sales totaling about $1.60 million: CFO Michael Wagnes sold 3,184 shares, SVP Timothy Eckersley sold 6,417 shares and CAO Nickolas Musial sold 687 shares. The transactions were made under pre-arranged Rule 10b5-1 plans where disclosed, reducing the likelihood that they reflect new concerns, but insider selling can still weigh on sentiment.
- Negative Sentiment: Analyst sentiment remains cautious. Allegion carries a consensus “Hold” rating with an average price target of $164.75, while several firms have reduced targets; the stock’s elevated valuation relative to expected growth may limit near-term upside.
Institutional Investors Weigh In On Allegion
Institutional investors have recently modified their holdings of the company. Oregon Public Employees Retirement Fund increased its stake in Allegion by 0.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 9,817 shares of the scientific and technical instruments company’s stock valued at $1,563,000 after purchasing an additional 59 shares in the last quarter. Diversify Advisory Services LLC boosted its position in Allegion by 2.7% during the third quarter. Diversify Advisory Services LLC now owns 2,308 shares of the scientific and technical instruments company’s stock worth $380,000 after purchasing an additional 60 shares in the last quarter. D.A. Davidson & CO. grew its holdings in Allegion by 4.1% in the fourth quarter. D.A. Davidson & CO. now owns 1,612 shares of the scientific and technical instruments company’s stock valued at $257,000 after purchasing an additional 63 shares during the last quarter. Banque de Luxembourg S.A. grew its holdings in Allegion by 0.3% in the fourth quarter. Banque de Luxembourg S.A. now owns 22,294 shares of the scientific and technical instruments company’s stock valued at $3,550,000 after purchasing an additional 65 shares during the last quarter. Finally, Hantz Financial Services Inc. increased its position in shares of Allegion by 45.9% in the fourth quarter. Hantz Financial Services Inc. now owns 216 shares of the scientific and technical instruments company’s stock valued at $34,000 after buying an additional 68 shares in the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.
Allegion Company Profile
Allegion plc (NYSE: ALLE) is a global provider of security products and solutions focused on ensuring the safety and security of people and property. The company was formed in December 2013 through a corporate spin-off from Ingersoll Rand and is headquartered in Dublin, Ireland. Allegion’s core mission is to deliver innovative mechanical and electronic access control systems for a wide range of end markets, including commercial buildings, residential properties, institutional facilities, and industrial sites.
The company’s product portfolio spans mechanical locksets, door closers, exit devices, key systems and cylinders, as well as a growing suite of electronic and smart access control offerings.
Read More
- Five stocks we like better than Allegion
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with MarketBeat.com's FREE daily email newsletter.
